JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, N.
Right arrow Articles by Sasaki, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, N.
Right arrow Articles by Sasaki, Y.
Journal of Nuclear Medicine Vol. 47 No. 10 1670-1677
© 2006 by Society of Nuclear Medicine


Basic Science Investigation

Molecular Therapy of Human Neuroblastoma Cells Using Auger Electrons of 111In-Labeled N-myc Antisense Oligonucleotides

Naoyuki Watanabe1, Hiroaki Sawai2, Izumi Ogihara-Umeda3, Shuji Tanada1, E. Edmund Kim4, Yoshiharu Yonekura1 and Yasuhito Sasaki1

1 Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan; 2 Department of Chemistry, Gunma University Graduate School, Gunma, Japan; 3 Department of Radiopharmacy, School of Pharmaceutical Sciences, Teikyo University, Kanagawa, Japan; and 4 Division of Diagnostic Imaging, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Correspondence: For correspondence or reprints contact: Naoyuki Watanabe, MD, PhD, Division of Human Health, International Atomic Energy Agency, Wagramer Strasse 5, P.O. Box 200, Vienna A-1400, Austria. E-mail: N.Watanabe{at}iaea.org

Auger electrons can create breaks in nucleic acids, giving them possible therapeutic utility. We investigated the therapeutic effect of Auger electrons emitted by 111In-labeled phosphorothioate antisense oligonucleotides on human neuroblastoma cells in which N-myc was overexpressed. Methods: Human SK-N-DZ neuroblastoma cells (5 x 106 cells) were treated with cationic reverse-phase evaporation vesicles (REVs) encapsulating 111In-labeled antisense (40 MBq/2 nmol of oligonucleotides/µmol of total phospholipids) that had an average diameter of 250 nm. Hybridization of the radiolabeled oligonucleotides with N-myc messenger RNA (mRNA), N-myc expression, and cell proliferation were investigated. The tumorigenicity of treated cells was analyzed in nude mice. Nonradiolabeled antisense, 111In-labeled sense, or empty cationic REVs were used as controls. Results: 111In-Labeled antisense, which hybridized with N-myc mRNA, was detected in cells at 12 and 24 h after the initiation of treatment. Reduced N-myc expression and inhibited cell proliferation were shown in the same cells at 48 h after the completion of treatment. N-myc expression–suppressed cells produced intraperitoneal tumors in nude mice, but the average weight of the tumors was lower than that of tumors in control mice. Conclusion: Auger electrons emitted from 111In in close proximity to their target N-myc mRNA may prolong the time to cell proliferation in human neuroblastoma cells due to inhibition of the translation of N-myc. Auger electron therapy therefore has potential as an internally delivered molecular radiotherapy targeting the mRNA of a tumor cell.

Key Words: Auger electrons • human neuroblastoma • N-myc expression • cell proliferation • molecular radiotherapy


Related articles in JNM:

This Month in JNM

JNM 2006 47: 9a-10a. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.